Biontech to present clinical data updates for next-generation immunotherapy candidates at the asco annual meeting 2024

Mainz, germany, may 21, 2024 – biontech se (nasdaq: bntx, “biontech” or “the company”) will present clinical trial data for selected programs from the company's diversified immuno-oncology pipeline at the american society of clinical oncology (“asco”) annual meeting in chicago, illinois, from may 31 to june 4, 2024. moreover, in support of the company's ongoing car-t cell and individualized mrna programs, biontech will also present epidemiological and real-world data from two observational studies in patient populations for which product candidates are being developed in the company's respective clinical programs.
BNTX Ratings Summary
BNTX Quant Ranking